Genworth Financial Inc (GNW)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Genworth Financial Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 10 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 9.80 $ — 86% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -4.9% failed
- More than 10% revenue growth is expected for the coming year no data
- Share count grows by less than 3% a year -6.8% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -5.7% failed
- Gross margin at 40% or higher and without meaningful erosion 24.3% failed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 6,637 m net cash passed
- Operating cash flow covers the profits of the last three years 414 m passed
- Return on capital at 15% or higher, or up versus two years ago 0.6% passed
- Insiders hold at least 10% or are net buyers 1.8% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 22.4% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 1
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.08 | 1.08 – 1.08 | 0 | – | 1 |
| 12/31/2027 | 1.10 | 1.10 – 1.10 | 0 | 1.8% | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.07 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.00 | – | 1,722 | -7.90 | -0.10 | 27 | 27 |
| 2025: Q1 | 0.13 | -58.60 | 1,778 | -3.60 | 3.00 | 34 | 34 |
| 2025: Q2 | 0.12 | -29.20 | 1,727 | -0.30 | 3.00 | 6 | 6 |
| 2025: Q3 | 0.28 | 43.90 | 1,873 | 1.60 | 6.20 | 87 | 87 |
| 2025: Q4 | 0.01 | – | 1,493 | -13.30 | 0.10 | 200 | 200 |
| 2026: Q1 | 0.12 | -6.50 | 1,723 | -3.10 | 2.70 | 91 | 91 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 8,363 | 320 | -277 | -0.56 | 1,852 | 12,644 | 104,658 |
| 2017 | 7,513 | 127 | 817 | 1.63 | 2,554 | 15,328 | 105,297 |
| 2018 | 8,430 | 569 | 119 | 0.24 | 1,633 | 14,189 | 100,923 |
| 2019 | 8,096 | 538 | 519 | 1.02 | 2,079 | 97,766 | 101,342 |
| 2020 | 8,658 | 448 | 761 | 1.49 | 1,960 | 102,220 | 105,747 |
| 2021 | 7,832 | 1,167 | 904 | 1.76 | 437 | 97,289 | 99,171 |
| 2022 | 7,396 | 1,365 | 916 | 1.79 | 1,049 | 10,739 | 86,442 |
| 2023 | 7,371 | 303 | 76 | 0.16 | 597 | 7,480 | 90,817 |
| 2024 | 7,143 | 595 | 299 | 0.68 | 88 | 8,494 | 86,871 |
| 2025 | 6,367 | 433 | 223 | 0.54 | 327 | 8,750 | 88,083 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Genworth Financial, Inc. bietet gemeinsam mit ihren Tochtergesellschaften Hypotheken- und Pflegeversicherungsprodukte in den USA an.
| Employees | 3,100 |
|---|---|
| Headquarters | Glen Allen, VA |
| Address | 11011 West Broad Street, 23060 Glen Allen, United States |
| Phone | 804 281 6000 |
| Website | genworth.com |
| IPO Date | 25. May 2004 |
| ISIN | US37247D1063 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Kelly Alison Saltzgaber | Executive VP & Chief Investment Officer | 1965 |
| Thomas Joseph McInerney | President, CEO & Director (Leave of Absence) | 1957 |
| Jamala Murray Arland | President & CEO of Genworth Insurance | 1982 |
| Samir B. Shah | President & CEO of CareScout | 1979 |
| Morris C. Taylor | Executive VP & Chief Information Officer | 1972 |
| Christine Jewell | Head of Investor Relations | – |
| John G. Apostle II | Chief Compliance Officer | – |
| Gregory Scott Karawan J.D. | Executive VP & General Counsel | 1965 |
| Melissa Hagerman | Executive VP & Chief Human Resources Officer | 1968 |
| Mark Blakeley Hodges | Executive VP & Chief Risk Officer | 1981 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 13. Jul 2026 | Shah Samir B. | Pres. & CEO, CareScout | Other | 8,160 | 9.47 | 77,275 |
| 13. Jul 2026 | Shah Samir B. | Pres. & CEO, CareScout | Other | 15,965 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.